ZA875951B - A cdna coding for carcinoembryonic antigen - Google Patents

A cdna coding for carcinoembryonic antigen

Info

Publication number
ZA875951B
ZA875951B ZA875951A ZA875951A ZA875951B ZA 875951 B ZA875951 B ZA 875951B ZA 875951 A ZA875951 A ZA 875951A ZA 875951 A ZA875951 A ZA 875951A ZA 875951 B ZA875951 B ZA 875951B
Authority
ZA
South Africa
Prior art keywords
nucleic acid
cea
carcinoembryonic antigen
detecting
cdna coding
Prior art date
Application number
ZA875951A
Other languages
English (en)
Inventor
R. Barnett Thomas
J. Elting James
E. Kamarck Michael
Original Assignee
Molecular Diagnostics Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Incorporated filed Critical Molecular Diagnostics Incorporated
Publication of ZA875951B publication Critical patent/ZA875951B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA875951A 1986-08-13 1987-08-12 A cdna coding for carcinoembryonic antigen ZA875951B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89636186A 1986-08-13 1986-08-13
US1668387A 1987-02-19 1987-02-19
US6003187A 1987-06-19 1987-06-19

Publications (1)

Publication Number Publication Date
ZA875951B true ZA875951B (en) 1988-02-19

Family

ID=27360631

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA875951A ZA875951B (en) 1986-08-13 1987-08-12 A cdna coding for carcinoembryonic antigen

Country Status (12)

Country Link
EP (1) EP0263933B1 (de)
JP (2) JP3253609B2 (de)
AT (1) ATE96168T1 (de)
AU (1) AU598573B2 (de)
DE (1) DE3787864T2 (de)
DK (1) DK173134B1 (de)
ES (1) ES2059330T3 (de)
FI (1) FI873478A (de)
IE (1) IE60279B1 (de)
IL (1) IL83484A (de)
NZ (1) NZ221385A (de)
ZA (1) ZA875951B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122599A (en) * 1986-08-13 1992-06-16 Molecular Diagnostics, Inc. CDNAS coding for members of the carcinoembryonic antigen family
JP2607492B2 (ja) * 1987-01-14 1997-05-07 サントリー株式会社 ヒト癌胎児性抗原
US4908417A (en) * 1988-05-17 1990-03-13 Sumitomo Chemical Company, Limited Thermosetting resin composition
JPH02107189A (ja) * 1988-05-25 1990-04-19 City Of Hope 癌胎児抗原フラグメント
EP0346702A3 (de) * 1988-06-16 1991-08-28 Miles Inc. Transfizierte Zellinien, die isolierte Gene der karzinoembryonale Antigenfamilie exprimieren
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
JP3399943B2 (ja) * 1991-05-06 2003-04-28 アメリカ合衆国 癌胎児性抗原を発現する組換えウイルスとその使用方法
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
JP4808365B2 (ja) * 2001-03-02 2011-11-02 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション Ｐｃｒ法
US8119352B2 (en) 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
EA201591888A1 (ru) 2008-03-14 2016-05-31 Санофи Пастер Байолоджикс Ко. Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
CN105175542B (zh) 2010-12-16 2018-12-18 弗·哈夫曼-拉罗切有限公司 与th2抑制相关的诊断和治疗
WO2014140938A2 (en) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Immunological methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4228236A (en) * 1978-05-15 1980-10-14 Northwestern University Process of producing carcinoembryonic antigen
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法

Also Published As

Publication number Publication date
FI873478A (fi) 1988-02-14
IE60279B1 (en) 1994-06-29
JPS63119681A (ja) 1988-05-24
AU598573B2 (en) 1990-06-28
JPH09136900A (ja) 1997-05-27
IL83484A0 (en) 1988-01-31
DK420487A (da) 1988-02-14
EP0263933B1 (de) 1993-10-20
IE872161L (en) 1988-02-13
DK420487D0 (da) 1987-08-12
ATE96168T1 (de) 1993-11-15
FI873478A0 (fi) 1987-08-11
JP3253609B2 (ja) 2002-02-04
EP0263933A1 (de) 1988-04-20
ES2059330T3 (es) 1994-11-16
DE3787864T2 (de) 1994-02-10
IL83484A (en) 1993-01-31
AU7686887A (en) 1988-03-24
NZ221385A (en) 1991-06-25
DK173134B1 (da) 2000-01-31
DE3787864D1 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
EP0346710A3 (de) cDNAs, die für Mitglieder der Karzinoembryonalantigen-Familie kodieren
IL83484A (en) Cdna coding for carcinoembryonic antigen
AU5909386A (en) Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
DK108589D0 (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer
EP0258411A4 (de) Dns, kodierend für streptavidin, daraus erzeugtes streptavidin, fusierte polypeptide mit aminosäurensequenzen aus streptavidin und verwendungen.
NL300197I1 (de)
HK1013847A1 (en) Gdf-1 and uog-1 proteins
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
IL87737A (en) Method for culturing polypeptide factor dependent vertebrate recombinant cells
DK73483A (da) Dna-sekvenser, rekombinant-dna-molekyler samt fremgangsmaader til fremstilling af human-immune interferonlignende polypeptider
ATE87655T1 (de) Markierer der t-zelle aktivierung.
HK1006854A1 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
IL97567A (en) Vaccines for the prevention of coccidiosis
DE3585790D1 (de) Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.
DK108189A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
KR890005270A (ko) 재조합 종두 비루스
ES555124A0 (es) Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
GB8501473D0 (en) Cloned dna sequences
NZ211357A (en) Recombinant dna and antigenic protein coded for
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
NO174970C (no) Rekombinant DNA, rekombinant DNA-vektor samt vertscelle
GR3033328T3 (en) Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis.
GB2182043B (en) Precursor polypeptide dna sequence coding therefor, vectors, host organisms and processes involving same
EP0253325A3 (de) Von Onkogenen abgeleitete Peptide
EP0293079A3 (de) Chlamydia-Vakzin